Thursday, June 13, 2013

IMPORTANT MEDICAL NEWS & THE LAW-URGENT !









THE SUPREME COURT RULES NO ONE COMPANY CAN OWN OUR GENES.
MYRIAD WAS UNDER FIRE & FINALLY THE COURT HEARD THE CASE & DECIDED, RIGHTFULLY IN MY OPINION..

AFTER ANGELINA JOLIE MADE NEWS ABOUT THE CANCER GENE (BRCA) SHE HAD WHICH LEAD TO HER MASTECTOMY , MANY WOMEN, UNDERSTANDABLY, WANTED TO BE TESTED BUT BECAUSE "MYRIAD" HAD DISCOVERED THE GENE THEY WANTED A MONOPOLY ON THE TEST FOR IT--APPROXIMATE COST? $3000.

AFTER TODAY'S RULING OTHER COMPANIES CAN NOW OFFER THE TEST, LOWERING THE COSTS DRAMATICALLY! YAY!

NOW THIS IS MAJOR GOOD NEWS:

FROM NOW ON, FOR BOTH MEN & WOMEN ALIKE, ACCORDING TO THE SUPREME COURT, NO ONE CAN OWN ANY PART OF OUR BODIES, REGARDLESS OF WHERE THE RESEARCH TOOK PLACE (EXCEPT IN THE CASE OF A SYNTHETIC DNA).

THIS IS MONUMENTAL!!!
___________________________________________________________
  (ACLU):

 "Much of the industry will be a winner in this," according to attorney Sandra Park, a member of the American Civil Liberties Union legal team that fought against Myriad. "There are many companies that want to offer genetic testing on patented genes. They've been unable to do that so far because of these types of patents."
______________________________________________________________

CBS NEWS:
The Supreme Court's ruling that human genes cannot be patented has been met with excitement from doctors over the implications for patient health. Other experts, however, questioned whether there will be a widespread impact.

The high court's ruling threw out some patents previously held by Myriad Genetics Inc., a Salt Lake City-based company that had patented a genetic test for the BRCA gene that's associated with increased risks for breast and ovarian cancers.

"We hold that a naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated," said Justice Clarence Thomas, who wrote the court's unanimous decision.

The court, however, also ruled that synthetic DNA -- called cDNA -- could be patented by a company.

The full decision of Association for Molecular Pathology et al. v. Myriad Genetics,Inc., et. al can be found on the Supreme Court's website.

No comments:

Post a Comment